Sciwind Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies for metabolic diseases. Its lead asset, ecnoglutide (XW003), is currently in the NDA stage in China. Leveraging proprietary platforms for oral peptide and long-acting protein therapeutics, Sc... Read more
This company has no org chart yet
This company has no teams yet
This company has no offices yet